Unity Software shares rebounded after the close following stronger preliminary first-quarter guidance, even as major US indices declined during regular trading. The stock ended the session down 3.76% at $17.13 before rising 12.49% in after-hours trading to $19.27. Unity projected first-quarter revenue of $505 million to $508 million, ahead of its earlier outlook of $480
The iShares 20+ Year Treasury Bond ETF (TLT) remains under intense pressure this year as investors have remained concerned about the ballooning US government debt and rising long-term bond yields. The TLT ETF stock dropped to $86, down by nearly 5% from its highest point this year. Soaring US debt has pushed investors to BIL
Foreign investors are on track to pull a record $12 billion from Indian equities in March, as rising oil prices and geopolitical tensions in the Middle East trigger a sharp reversal in sentiment toward emerging markets. With just two trading sessions left in the month, foreign portfolio investors (FPIs) have already withdrawn Rs 1.12 trillion
After trading above $91 in early March, Solana (SOL) has seen repeated rejection around that range. The price is currently hovering around $84, indicating a short-term decline from recent highs. Solana had surged past $96 following Trump’s announcement that the United States was pausing its intended attacks on Iran’s energy and power infrastructure, but afterwards
Cardano’s slide to near $0.24 on Friday has injected fresh investor concern, with the token underperforming alongside sharp pullbacks in Bitcoin and Ethereum. The move, which has seen the ADA price down 4% in the past 24 hours and 9% this past week, has revived fears that the bear phase may yet have another leg
Wall Street opened lower on Friday, as the ongoing Middle East conflict continued to weigh on investor sentiment despite a delay in potential US military action against Iran’s energy infrastructure. The Dow Jones Industrial Average fell 333 points, or 0.7%, while the S&P 500 slipped 0.6% and the Nasdaq 100 declined 0.75%. The cautious tone
Shares of AstraZeneca rose on Friday after the drugmaker reported positive results from late-stage clinical trials of its experimental chronic obstructive pulmonary disease (COPD) treatment, tozorakimab. The UK-based pharmaceutical company said the drug candidate met its primary objective in two Phase 3 studies, OBERON and TITANIA, marking a significant milestone in its respiratory pipeline. The
XPeng stock price has held steady in the past few days, helped by the recent financial results, which showed that it made its first quarterly profit. XPEV was trading at $18.85 on Wednesday, up 23% from its lowest point this year. What’s next for this Chinese EV giant? XPeng delivers first quarterly profit, but potential
The artificial intelligence space has been making all the noise on Wall Street for the past two years. With soaring valuations, the chip giants like Nvidia or other hyperscalers such as Microsoft, Amazon, and Alphabet seem to be dominating the sector. Now, Bank of America is making a more specific bet that a newer class
The MSTR stock has held steady in the past two months, coinciding with the ongoing Bitcoin price action. Strategy was trading at $139 on Wednesday, up slightly from the year-to-date low of $105. Bitcoin price has formed a big bearish flag pattern The main reason why the MSTR stock price may continue falling in the